Trial NCT00009919

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02373
Secondary IDs: CDR0000068424 ID99-291 N01CM17003

Last trial update was posted on 2013-01-23

MeSH Interventions

Semaxinib

MeSH Conditions

Carcinoma, Renal Cell

Other Conditions

Recurrent Renal Cell Cancer Stage IV Renal Cell Cancer

Stopping Reasons

Administratively complete.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID